Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
PLSE
#1951
Pulse Biosciences, Inc Common Stock (DE)
18.730
0
-0.58%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-0.58%
Aylık değişim
+30.89%
6 aylık değişim
+3.20%
Yıllık değişim
+3.20%
Önceki kapanış
18.840
0
Open
18.730
0
Bid
Ask
Low
18.730
0
High
18.730
0
Hacim
54
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
PLSE
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
26.09 M
29.8 M
37.59 M
55.23 M
67.27 M
67.99 M
—
Valuation ratios
Enterprise value
609.97 M
412.76 M
42.24 M
564.22 M
1.05 B
852.76 M
3.83 B
Price to earnings ratio
—
—
-1.6
-12.54
-18.97
12.71
-32.93
Price to sales ratio
—
—
133.32
—
—
2 643.82
—
Price to cash flow ratio
—
—
-1.99
-16.02
-27.98
17.1
-53.09
Price to book ratio
—
—
-41.51
11.93
8.85
11.47
19.35
Enterprise value to EBITDA ratio
-12.35
-12.19
-1.16
-36.96
—
-11.14
—
Profitability ratios
Return on assets %
1.21
1.17
0.75
0.71
0.4
-0.77
0.28
Return on equity %
2.18
1.78
26.03
0.95
0.47
-0.9
0.32
Return on invested capital %
761.9
1 240.68
1 276.4
1 075.01
1 538.65
-2 275.12
—
Gross margin %
—
-38.79
-1 606.29
—
—
-54
—
Operating margin %
—
4 443.86
8 293.86
—
—
-21.98 K
—
EBITDA margin %
—
-2 388.86
-5 190.43
—
—
-21.87 K
—
Net margin %
—
4 492.24
8 357.86
—
—
-20.79 K
—
Liquidity ratios
Quick ratio
—
3.62
10.39
—
—
10.51
48.14
Current ratio
2.95
4.3
10.39
6.76
11.88
10.53
48.17
Inventory turnover
—
0.1
2.91
—
—
—
—
Asset turnover
0
0.03
0.01
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.01
0
0
—
—
—
Long term debt to total equity ratio
—
0.01
0
0
—
—
—
Per share metrics
Operating cash flow per share
—
—
1.39
0.69
0.62
-0.8
0.37
EBIT per share
—
—
-1.11
-0.34
—
-1.15
—
EBITDA per share
—
—
-1.07
-0.32
—
-1.14
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.8
0.92
2.02
1.2
5.97
Net current asset value per share
—
—
1.83
0.94
2.05
1.24
6.09
Tangible book value per share
—
—
0.14
0.99
2.03
1.27
6.15
Working capital per share
—
—
1.66
0.8
1.87
1.12
5.58
Book value per share
—
—
0.07
0.92
1.97
1.2
5.89
Haberler
Pulse Biosciences ticari direktörü derhal istifa etti
Pulse Biosciences chief commercial officer resigns effective immediately
Pulse Biosciences CCO Danahy 118 bin dolarlık hisse sattı
Pulse Biosciences CCO Danahy sells $118k in PLSE stock
Oppenheimer, Pulse Biosciences için hisse hedefini 30 dolara yükseltti
Oppenheimer raises Pulse Biosciences stock price target to $30
Pulse Biosciences, Inc. (PLSE) Q4 2025 Earnings Call Transcript
Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates
Pulse Biosciences kazancı $0,07 ile beklentilere göre daha iyi, kâr ise beklentilere göre düşük
Pulse Biosciences’ın kazançları klinik veri artışından sonra odak noktasında
Walmart, Southern Co, Newmont Mining and more set to report earnings Thursday
Pulse Biosciences CCO Danahy 1,41 milyon dolarlık hisse satışı gerçekleştirdi